{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:30:37Z","timestamp":1786329037071,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11916-026-01546-9","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:27:30Z","timestamp":1786328850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1-Based Therapies in Pain Medicine: A Narrative Review and Expert Opinion on Obesity-Related Low Back and Knee Pain"],"prefix":"10.1007","volume":"30","author":[{"given":"Jamal","family":"Hasoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvinh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Urits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"1546_CR1","doi-asserted-by":"publisher","unstructured":"Dahlhamer J, Lucas J, Zelaya C, Nahin R, Mackey S, DeBar L, Kerns R, Von Korff M, Porter L, Helmick C. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001\u20136. https:\/\/doi.org\/10.15585\/mmwr.mm6736a2.","DOI":"10.15585\/mmwr.mm6736a2"},{"issue":"6","key":"1546_CR2","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/S2665-9913(23)00098-X","volume":"5","author":"GBD 2021 Low Back Pain Collaborators","year":"2023","unstructured":"GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990\u20132020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(6):e316\u201329. https:\/\/doi.org\/10.1016\/S2665-9913(23)00098-X. PMID: 37273833; PMCID: PMC10234592.","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"1546_CR3","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","volume":"5","author":"GBD 2021 Osteoarthritis Collaborators","year":"2023","unstructured":"GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508\u201322. https:\/\/doi.org\/10.1016\/S2665-9913(23)00163-7. PMID: 37675071; PMCID: PMC10477960.","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"1546_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41584-024-01143-3","volume":"20","author":"M Binvignat","year":"2024","unstructured":"Binvignat M, Sellam J, Berenbaum F, Felson DT. The role of obesity and adipose tissue dysfunction in osteoarthritis pain. Nat Rev Rheumatol. 2024;20(9):565\u201384. https:\/\/doi.org\/10.1038\/s41584-024-01143-3. Epub 2024 Aug 7. PMID: 39112603.","journal-title":"Nat Rev Rheumatol"},{"key":"1546_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fnhum.2020.00181","volume":"14","author":"T Eichwald","year":"2020","unstructured":"Eichwald T, Talbot S. Neuro-Immunity Controls Obesity-Induced Pain. Front Hum Neurosci. 2020;14:181. https:\/\/doi.org\/10.3389\/fnhum.2020.00181. PMID: 32581740; PMCID: PMC7295985.","journal-title":"Front Hum Neurosci"},{"issue":"2","key":"1546_CR6","first-page":"1279","volume":"20","author":"X Guo","year":"2019","unstructured":"Guo X, Tao X, Tong Q, Li T, Dong D, Zhang B, Zhao M, Song T. Impaired AMPK\u2013CGRP signaling in the central nervous system contributes to enhanced neuropathic pain in high\u2013fat diet\u2013induced obese rats, with or without nerve injury. Mol Med Rep. 2019;20(2):1279\u201387. Epub 2019 Jun 6. PMID: 31173269; PMCID: PMC6625401.","journal-title":"Mol Med Rep"},{"issue":"11","key":"1546_CR7","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1038\/s41366-025-01881-8","volume":"49","author":"D Menoth Mohan","year":"2025","unstructured":"Menoth Mohan D, Al Anouti F, Kohli N, Khalaf K. Association of obesity with musculoskeletal health and functional mobility in females-a systematic review. Int J Obes (Lond). 2025;49(11):2184\u2013205. https:\/\/doi.org\/10.1038\/s41366-025-01881-8. Epub 2025 Sep 18. PMID: 40968131; PMCID: PMC12583141.","journal-title":"Int J Obes (Lond)"},{"issue":"12","key":"1546_CR8","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1467-789X.2011.00916.x","volume":"12","author":"J Runhaar","year":"2011","unstructured":"Runhaar J, Koes BW, Clockaerts S, Bierma-Zeinstra SM. A systematic review on changed biomechanics of lower extremities in obese individuals: a possible role in development of osteoarthritis. Obes Rev. 2011;12(12):1071\u201382. https:\/\/doi.org\/10.1111\/j.1467-789X.2011.00916.x. Epub 2011 Aug 3. PMID: 21812903.","journal-title":"Obes Rev"},{"key":"1546_CR9","doi-asserted-by":"publisher","unstructured":"Rosen CJ, Ingelfinger JR. GLP-1 Receptor Agonists. N Engl J Med. 2026;394(13):1313\u20131324. https:\/\/doi.org\/10.1056\/NEJMra2500106","DOI":"10.1056\/NEJMra2500106"},{"key":"1546_CR10","doi-asserted-by":"publisher","unstructured":"Celletti F, Farrar J, De Regil L. World health organization guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults. JAMA. 2026;335(5):434\u2013438. https:\/\/doi.org\/10.1001\/jama.2025.24288","DOI":"10.1001\/jama.2025.24288"},{"issue":"20","key":"1546_CR11","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity Management in Adults: A Review. JAMA. 2023;330(20):2000\u201315. https:\/\/doi.org\/10.1001\/jama.2023.19897. PMID: 38015216; PMCID: PMC11325826.","journal-title":"JAMA"},{"issue":"2","key":"1546_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/aje\/kwp356","volume":"171","author":"R Shiri","year":"2010","unstructured":"Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Viikari-Juntura E. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol. 2010;171(2):135\u201354. https:\/\/doi.org\/10.1093\/aje\/kwp356. Epub 2009 Dec 11. PMID: 20007994.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1546_CR13","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1186\/s12889-024-20011-z","volume":"24","author":"I Heuch","year":"2024","unstructured":"Heuch I, Heuch I, Hagen K, Zwart JA. Overweight and obesity as risk factors for chronic low back pain: a new follow-up in the HUNT Study. BMC Public Health. 2024;24(1):2618. https:\/\/doi.org\/10.1186\/s12889-024-20011-z. PMID: 39334024; PMCID: PMC11437722.","journal-title":"BMC Public Health"},{"issue":"1","key":"1546_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00586-021-06994-y","volume":"31","author":"Q You","year":"2022","unstructured":"You Q, Jiang Q, Li D, Wang T, Wang S, Cao S. Waist circumference, waist-hip ratio, body fat rate, total body fat mass and risk of low back pain: a systematic review and meta-analysis. Eur Spine J. 2022;31(1):123\u201335. https:\/\/doi.org\/10.1007\/s00586-021-06994-y. Epub 2021 Sep 24. PMID: 34561729.","journal-title":"Eur Spine J"},{"key":"1546_CR15","doi-asserted-by":"publisher","unstructured":"Bharti PS, Gorai PK, Dutt H, Gupta Y, Malik G, Rani N, Shankar V. Obesity-induced intervertebral disk degeneration: pathophysiology and clinical implications. Int J Obes (Lond). 2026 Jun 29. https:\/\/doi.org\/10.1038\/s41366-026-02130-2","DOI":"10.1038\/s41366-026-02130-2"},{"issue":"1","key":"1546_CR16","doi-asserted-by":"publisher","first-page":"e3224","DOI":"10.1002\/dmrr.3224","volume":"36","author":"F Cannata","year":"2020","unstructured":"Cannata F, Vadal\u00e0 G, Ambrosio L, Fallucca S, Napoli N, Papalia R, Pozzilli P, Denaro V. Intervertebral disc degeneration: A focus on obesity and type 2 diabetes. Diabetes Metab Res Rev. 2020;36(1):e3224. https:\/\/doi.org\/10.1002\/dmrr.3224. Epub 2019 Nov 16. PMID: 31646738.","journal-title":"Diabetes Metab Res Rev"},{"key":"1546_CR17","doi-asserted-by":"publisher","unstructured":"Hashem LE, Roffey DM, Alfasi AM, Papineau GD, Wai DC, Phan P, Kingwell SP, Wai EK. Exploration of the inter-relationships between obesity, physical inactivity, inflammation, and low back pain. Spine (Phila Pa 1976). 2018;43(17):1218\u20131224. https:\/\/doi.org\/10.1097\/BRS.0000000000002582","DOI":"10.1097\/BRS.0000000000002582"},{"key":"1546_CR18","doi-asserted-by":"publisher","first-page":"1538754","DOI":"10.3389\/fmed.2025.1538754","volume":"12","author":"Z Que","year":"2025","unstructured":"Que Z, Chen D, Cai H, Lan W, Huang Y, Rui G. Associations between insulin resistance and low back pain risk in US adults: a cross-sectional study. Front Med (Lausanne). 2025;12:1538754. https:\/\/doi.org\/10.3389\/fmed.2025.1538754. PMID: 40357296; PMCID: PMC12066540.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1546_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41584-021-00713-z","volume":"18","author":"V Francisco","year":"2022","unstructured":"Francisco V, Pino J, Gonz\u00e1lez-Gay M\u00c1, Lago F, Karppinen J, Tervonen O, Mobasheri A, Gualillo O. A new immunometabolic perspective of intervertebral disc degeneration. Nat Rev Rheumatol. 2022;18(1):47\u201360. https:\/\/doi.org\/10.1038\/s41584-021-00713-z. Epub 2021 Nov 29. PMID: 34845360.","journal-title":"Nat Rev Rheumatol"},{"key":"1546_CR20","doi-asserted-by":"publisher","first-page":"1355503","DOI":"10.3389\/fimmu.2024.1355503","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Du J, Huang Y, Gao S, Zhao Z, Chang Z, Zhang X, He B. From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration. Front Immunol. 2024;15:1355503. https:\/\/doi.org\/10.3389\/fimmu.2024.1355503. PMID: 38444852; PMCID: PMC10912372.","journal-title":"Front Immunol"},{"key":"1546_CR21","doi-asserted-by":"publisher","unstructured":"Morelh\u00e3o PK, Saj Porcacchia A, Gobbi C, Franco MR, Kakazu VA, Tufik S, Andersen ML, Pinto RZ. Does sleep quality mediate the association of depressive symptoms with pain and disability in older adults with low back pain? A longitudinal population-based study. Pain Med. 2026;27(6):671\u2013677. https:\/\/doi.org\/10.1093\/pm\/pnag011","DOI":"10.1093\/pm\/pnag011"},{"key":"1546_CR22","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.2147\/JPR.S471401","volume":"17","author":"H Jiang","year":"2024","unstructured":"Jiang H, Zhang X, Liang J. The Combined Effect Between Sleep Disorders and Depression Symptoms on Chronic Low Back Pain: A Cross-Sectional Study of NHANES. J Pain Res. 2024;17:2777\u201387. PMID: 39220223; PMCID: PMC11363950.","journal-title":"J Pain Res"},{"key":"1546_CR23","doi-asserted-by":"publisher","unstructured":"Lemes \u00cdR, Pinto RZ, Turi Lynch BC, Codogno JS, Oliveira CB, Ross LM, Ara\u00fajo Fernandes R, Monteiro HL. The association between leisure-time physical activity, sedentary behavior, and low back pain: a cross-sectional analysis in primary care settings. Spine (Phila Pa 1976). 2021;46(9):596\u2013602. https:\/\/doi.org\/10.1097\/BRS.0000000000003996","DOI":"10.1097\/BRS.0000000000003996"},{"issue":"1","key":"1546_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12891-022-05391-w","volume":"23","author":"LH Chen","year":"2022","unstructured":"Chen LH, Weber K, Mehrabkhani S, Baskaran S, Abbass T, Macedo LG. The effectiveness of weight loss programs for low back pain: a systematic review. BMC Musculoskelet Disord. 2022;23(1):488. https:\/\/doi.org\/10.1186\/s12891-022-05391-w. PMID: 35606809; PMCID: PMC9125929.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1546_CR25","first-page":"CD016276","volume":"1","author":"E Mudd","year":"2026","unstructured":"Mudd E, Tutty A, Kamper SJ, Cashin AG, Michaleff ZA, Davidson SR, Alves E, Browne S, Linton J, McAuley JH, Williams CM. Weight management for chronic low back pain. Cochrane Database Syst Rev. 2026;1(1):CD016276. PMID: 41568755; PMCID: PMC12825355.","journal-title":"Cochrane Database Syst Rev"},{"key":"1546_CR26","doi-asserted-by":"publisher","unstructured":"Stefanova I, Currie AC, Newton RC, Albon L, Slater G, Hawkins W, Pring C. A meta-analysis of the impact of bariatric surgery on back pain. Obes Surg. 2020;30(8):3201\u20133207. https:\/\/doi.org\/10.1007\/s11695-020-04713-y","DOI":"10.1007\/s11695-020-04713-y"},{"issue":"5","key":"1546_CR27","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.spinee.2025.10.014","volume":"26","author":"K Aboushaala","year":"2026","unstructured":"Aboushaala K, Ibrahim O, Ahmed N, Aboushaala R, Patel SN, Ward SO, Savoia A, Westrick J, Juarez L, Hilton S, Skertich N, Spagnoli A, Torquati A, Omotosho P, Singh K. The effects of metabolic and bariatric surgery on spinal alignment, radiological, and clinical outcomes in morbidly obese patients with LBP: a systematic review and meta-analysis. Spine J. 2026;26(5):968\u201380. https:\/\/doi.org\/10.1016\/j.spinee.2025.10.014. Epub 2025 Oct 13. PMID: 41093066.","journal-title":"Spine J"},{"issue":"7","key":"1546_CR28","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/jcm10071443","volume":"10","author":"FW Koremans","year":"2021","unstructured":"Koremans FW, Chen X, Das A, Diwan AD. Changes in Back Pain Scores after Bariatric Surgery in Obese Patients: A Systematic Review and Meta-Analysis. J Clin Med. 2021;10(7):1443. https:\/\/doi.org\/10.3390\/jcm10071443. PMID: 33916220; PMCID: PMC8036450.","journal-title":"J Clin Med"},{"key":"1546_CR29","doi-asserted-by":"publisher","unstructured":"Wu JS, Lin LY, Sun JW, Yu WT, Yuliani FS, Lin SH. Musculoskeletal outcomes of glucagon-like peptide-1 receptor agonists versus other antiobesity agents in nondiabetic adults. Obesity (Silver Spring). 2026. https:\/\/doi.org\/10.1002\/oby.70218","DOI":"10.1002\/oby.70218"},{"issue":"10","key":"1546_CR30","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/oby.20835","volume":"22","author":"ZY Zhou","year":"2014","unstructured":"Zhou ZY, Liu YK, Chen HL, Liu F. Body mass index and knee osteoarthritis risk: a dose-response meta-analysis. Obes (Silver Spring). 2014;22(10):2180\u20135. https:\/\/doi.org\/10.1002\/oby.20835. Epub 2014 Jul 3. PMID: 24990315.","journal-title":"Obes (Silver Spring)"},{"issue":"8","key":"1546_CR31","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/art.39707","volume":"68","author":"C Reyes","year":"2016","unstructured":"Reyes C, Leyland KM, Peat G, Cooper C, Arden NK, Prieto-Alhambra D. Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis: A Population-Based Cohort Study. Arthritis Rheumatol. 2016;68(8):1869\u201375. https:\/\/doi.org\/10.1002\/art.39707. PMID: 27059260; PMCID: PMC4966641.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"1546_CR32","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/obr.12726","volume":"19","author":"IJH Chu","year":"2018","unstructured":"Chu IJH, Lim AYT, Ng CLW. Effects of meaningful weight loss beyond symptomatic relief in adults with knee osteoarthritis and obesity: a systematic review and meta-analysis. Obes Rev. 2018;19(11):1597\u2013607. https:\/\/doi.org\/10.1111\/obr.12726. Epub 2018 Jul 27. PMID: 30051952.","journal-title":"Obes Rev"},{"key":"1546_CR33","doi-asserted-by":"publisher","unstructured":"Atukorala I, Makovey J, Lawler L, Messier SP, Bennell K, Hunter DJ. Is there a dose-response relationship between weight loss and symptom improvement in persons with knee osteoarthritis? Arthritis Care Res (Hoboken). 2016;68(8):1106-14. https:\/\/doi.org\/10.1002\/acr.22805","DOI":"10.1002\/acr.22805"},{"issue":"12","key":"1546_CR34","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jama.2013.277669","volume":"310","author":"SP Messier","year":"2013","unstructured":"Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, Beavers DP, Hunter DJ, Lyles MF, Eckstein F, Williamson JD, Carr JJ, Guermazi A, Loeser RF. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;310(12):1263\u201373. https:\/\/doi.org\/10.1001\/jama.2013.277669. PMID: 24065013; PMCID: PMC4450354.","journal-title":"JAMA"},{"issue":"4","key":"1546_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.joca.2024.08.012","volume":"33","author":"A Shahid","year":"2025","unstructured":"Shahid A, Thirumaran AJ, Christensen R, Venkatesha V, Henriksen M, Bowden JL, Hunter DJ. Comparison of weight loss interventions in overweight and obese adults with knee osteoarthritis: A systematic review and network meta-analysis of randomized trials. Osteoarthritis Cartilage. 2025;33(4):518\u201329. Epub 2024 Sep 2. PMID: 39233046.","journal-title":"Osteoarthritis Cartilage"},{"key":"1546_CR36","doi-asserted-by":"publisher","unstructured":"Gudzune KA, Kushner RF. Medications for obesity: a review. JAMA. 2024;332(7):571\u2013584. https:\/\/doi.org\/10.1001\/jama.2024.10816","DOI":"10.1001\/jama.2024.10816"},{"key":"1546_CR37","doi-asserted-by":"publisher","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP, SCALE obesity and prediabetes NN8022-1839 study group. A randomized, controlled trial of 3.0\u00a0mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1411892","DOI":"10.1056\/NEJMoa1411892"},{"issue":"1","key":"1546_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/dom.14863","volume":"25","author":"NC Bergmann","year":"2023","unstructured":"Bergmann NC, Davies MJ, Lingvay I, Knop FK. Semaglutide for the treatment of overweight and obesity: A review. Diabetes Obes Metab. 2023;25(1):18\u201335. https:\/\/doi.org\/10.1111\/dom.14863. Epub 2022 Oct 18. PMID: 36254579; PMCID: PMC10092086.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"1546_CR39","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, Hjerpsted JB. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242\u201351. https:\/\/doi.org\/10.1111\/dom.12932. Epub 2017 May 5. PMID: 28266779; PMCID: PMC5573908.","journal-title":"Diabetes Obes Metab"},{"issue":"14","key":"1546_CR40","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D. STEP 4 Investigators. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414\u201325. https:\/\/doi.org\/10.1001\/jama.2021.3224. PMID: 33755728; PMCID: PMC7988425.","journal-title":"JAMA"},{"issue":"10","key":"1546_CR41","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","volume":"28","author":"WT Garvey","year":"2022","unstructured":"Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, J\u00f3dar E, Kandler K, Rigas G, Wadden TA, Wharton S, STEP 5 Study Group. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083\u201391. https:\/\/doi.org\/10.1038\/s41591-022-02026-4. Epub 2022 Oct 10. PMID: 36216945; PMCID: PMC9556320.","journal-title":"Nat Med"},{"issue":"8","key":"1546_CR42","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF, STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553\u201364. https:\/\/doi.org\/10.1111\/dom.14725. Epub 2022 May 19. PMID: 35441470; PMCID: PMC9542252.","journal-title":"Diabetes Obes Metab"},{"key":"1546_CR43","doi-asserted-by":"publisher","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A. SURMOUNT-1 investigators. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u2013216. https:\/\/doi.org\/10.1056\/NEJMoa2206038","DOI":"10.1056\/NEJMoa2206038"},{"issue":"10402","key":"1546_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","volume":"402","author":"WT Garvey","year":"2023","unstructured":"Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM. SURMOUNT-2 investigators. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402(10402):613\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(23)01200-X. Epub 2023 Jun 26. PMID: 37385275.","journal-title":"Lancet"},{"issue":"5","key":"1546_CR45","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1097\/HEP.0000000000001608","volume":"83","author":"MB Bansal","year":"2026","unstructured":"Bansal MB, Patton H, Morgan TR, Carr RM, Dranoff JA, Allen AM. Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance. Hepatology. 2026;83(5):1326\u201340. Epub 2025 Nov 7. PMID: 41201884.","journal-title":"Hepatology"},{"issue":"5","key":"1546_CR46","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamainternmed.2022.0338","volume":"182","author":"L He","year":"2022","unstructured":"He L, Wang J, Ping F, Yang N, Huang J, Li Y, Xu L, Li W, Zhang H. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med. 2022;182(5):513\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2022.0338. PMID: 35344001; PMCID: PMC8961394.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1546_CR47","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1053\/j.gastro.2025.06.003","volume":"169","author":"CH Chiang","year":"2025","unstructured":"Chiang CH, Jaroenlapnopparat A, Colak SC, Yu CC, Xanthavanij N, Wang TH, See XY, Lo SW, Ko A, Chang YC, Song J, Hsia YP, Chiang CH. Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis. Gastroenterology. 2025;169(6):1268\u201381. https:\/\/doi.org\/10.1053\/j.gastro.2025.06.003. Epub 2025 Jun 9. PMID: 40499738.","journal-title":"Gastroenterology"},{"issue":"5","key":"1546_CR48","doi-asserted-by":"publisher","first-page":"e70113","DOI":"10.1002\/edm2.70113","volume":"8","author":"J Wen","year":"2025","unstructured":"Wen J, Nadora D, Bernstein E, How-Volkman C, Truong A, Joy B, Kou M, Muttalib Z, Alam A, Frezza E. Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Endocrinol Diabetes Metab. 2025;8(5):e70113. https:\/\/doi.org\/10.1002\/edm2.70113. PMID: 40988099; PMCID: PMC12457091.","journal-title":"Endocrinol Diabetes Metab"},{"issue":"9","key":"1546_CR49","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jacc.2020.05.037","volume":"76","author":"SR Das","year":"2020","unstructured":"Das SR, Everett BM, Birtcher KK, Brown JM, Januzzi JL Jr, Kalyani RR, Kosiborod M, Magwire M, Morris PB, Neumiller JJ, Sperling LS. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020;76(9):1117\u201345. Epub 2020 Aug 5. PMID: 32771263; PMCID: PMC7545583.","journal-title":"J Am Coll Cardiol"},{"issue":"10296","key":"1546_CR50","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","volume":"398","author":"E Brown","year":"2021","unstructured":"Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet. 2021;398(10296):262\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(21)00536-5. Epub 2021 Jun 30. PMID: 34216571.","journal-title":"Lancet"},{"issue":"10","key":"1546_CR51","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1210\/clinem\/dgaf335","volume":"110","author":"Z Liu","year":"2025","unstructured":"Liu Z, Weeldreyer NR, Angadi SS. Incretin Receptor Agonism, Fat-free Mass, and Cardiorespiratory Fitness: A Narrative Review. J Clin Endocrinol Metab. 2025;110(10):2709\u201317. https:\/\/doi.org\/10.1210\/clinem\/dgaf335. PMID: 40488294; PMCID: PMC12448640.","journal-title":"J Clin Endocrinol Metab"},{"key":"1546_CR52","doi-asserted-by":"publisher","unstructured":"Prokopidis K. Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults: risks beyond muscle mass reductions. Br J Pharmacol. 2026. https:\/\/doi.org\/10.1111\/bph.70355","DOI":"10.1111\/bph.70355"},{"issue":"12","key":"1546_CR53","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.cgh.2024.10.003","volume":"23","author":"TL Kindel","year":"2025","unstructured":"Kindel TL, Wang AY, Wadhwa A, Schulman AR, Sharaiha RZ, Kroh M, Ghanem OM, Levy S, Joshi GP, LaMasters TL, American Gastroenterological Association; American Society for Metabolic and Bariatric Surgery; American Society of Anesthesiologists; International Society of Perioperative Care of Patients with Obesity; Society of American Gastrointestinal and Endoscopic Surgeons. Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period. Clin Gastroenterol Hepatol. 2025;23(12):2083\u20135. https:\/\/doi.org\/10.1016\/j.cgh.2024.10.003. Epub 2024 Oct 29. PMID: 39480373.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01546-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-026-01546-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01546-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:27:31Z","timestamp":1786328851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-026-01546-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1546"],"URL":"https:\/\/doi.org\/10.1007\/s11916-026-01546-9","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"18 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jamal Hasoon, Omar Viswanath, and Christopher L Robinson are Section Editors for Current Pain and Headache Reports. The authors were not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"105"}}